No Data
No Data
Cathie Wood Buys More NVIDIA And AMD Stock As Chinese Tech Giants Stockpile Chips Amid Looming US Export Curbs
10x Genomics to Report First Quarter 2025 Financial Results on May 8, 2025
Life Sciences Companies Likely to See Surprisingly Good 1Q Results -- Market Talk
BofA Securities Maintains 10x Genomics(TXG.US) With Hold Rating, Cuts Target Price to $12
BofA Securities Cuts Price Target on 10x Genomics to $12 From $16, Neutral Rating Maintained
Cathie Wood's ARK Investment Buys 191.5K Shares of 10x Genomics Today